The random peptides was just turning people into lab rats for no benefit. I see people using peptides with almost no research and no safety profile behind them when well researched alternatives already exist. People are treating these peptides that never made it to market as some big pharma conspiracy but we already saw that big pharma has no problem selling peptides. Some of the discords I was in people were on these 10-15 peptide cocktails espousing the benefits like they knew.
This is always my first thought with any pharma product that made it passed costly initial development. and was canned when testing started.
Pharma is never required to report problems or dangers discovered during the development process. The FDA helps keep these issues confidential as they'd negatively affect the business.
The public only sees the polished finished product once it starts trials, and even then, somebody dies, they can close up and never report the details publicly.
80% of peptide drugs fail in late stages of development.
People don't realize the intense scrutiny these protein drugs must be put under because of the potential consequences.
"In silico" testing, where they predict every potential thing that can go wrong, degradation, aggregation, manufacturing by products, and each of those contaminants is checked to estimate its potential harm.
If one thing changes, 1 degree of temperature in the manufacturing room, a different stopper material in the vial, it's got to be checked again for potentially new proteins that can form.
AAS are like bricks, these are microchips by comparison.